phase readout
saveNCT04217278: A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: University of Birmingham. Phase: PHASE2. Conditions: Acute Myeloid Leukaemia, High-risk Myelodysplastic Syndrome
view source ↗
comments(0)
5-min edit window · permanent after that